date,title,source
Oct-25-18,Aerpio Pharmaceuticals Announces Presentation of Renal Function Data from TIME-2 Study of AKB-9778 in Diabetic Retinopathy Patients at American Society of Nephrology Kidney Week 2018,Business Wire
Oct-31-18,"Aerpio Pharmaceuticals to Announce Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, November 7, 2018",Business Wire
Nov-07-18,Aerpio Reports Third Quarter 2018 Financial Results and Provides Business Update,Business Wire
Nov-08-18,Aerpio Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference,Business Wire
Nov-14-18,"Recent Analysis Shows Atlas Financial, Royal Dutch Shell, Vaalco Energy, Myovant Sciences, Aerpio Pharmaceuticals, and Wheeler Real Estate Investment Trust Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Nov-28-18,Cincinnati stocks soar as Dow Jones posts one of its five biggest gains ever,American City Business Journals
Jan-17-19,Aerpio Pharmaceuticals Announces Completion of Patient Dosing in TIME-2b Study of AKB-9778 in Diabetic Retinopathy,Business Wire
Jan-22-19,Aerpio (ARPO) Jumps: Stock Rises 7.8%,Zacks
Feb-26-19,"Aerpio Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, March 5, 2019",Business Wire
